Related Experiment Video
Updated: Aug 3, 2026

Fabrication of Electrochemical-DNA Biosensors for the Reagentless Detection of Nucleic Acids, Proteins and Small Molecules
Published on: June 1, 2011
Test Strip Platform Spin-Off for Telomerase Activity Detection: Development of an Electrochemical Biosensor
Ramonita Díaz-Ayala1, Marjorie López-Nieves1, Etienne S Colón Berlingeri1
1BIDEA LLC, Molecular Science Research Center, Lab 2-43, 1390 Ave. Ponce de León, San Juan 002926-2614, Puerto Rico.
A novel biosensing strip detects telomerase activity, a cancer biomarker, using electrochemical impedance spectroscopy. This technology shows promise for early cancer detection and distinguishing between cancerous and non-cancerous uterine biopsy samples.
Area of Science:
- Biomedical Engineering
- Oncology
- Analytical Chemistry
Background:
- Telomerase is a key cancer biomarker due to its overexpression in cancer cells.
- Existing methods for telomerase detection can be complex and time-consuming.
- There is a need for rapid, portable, and sensitive cancer biomarker detection tools.
Purpose of the Study:
- To develop and validate a novel biosensing strip (BBS) for detecting telomerase activity (TA).
- To utilize electrochemical impedance spectroscopy (EIS) for sensitive TA detection.
- To assess the feasibility of BBS for distinguishing between cancerous and non-cancerous clinical samples.
Main Methods:
- A gold interdigital electrode array (GID) was modified with immobilized single-strand DNA (ssDNA) probes.
- The BBS was exposed to telomerase-positive cell extracts and uterine biopsy samples.
- Electrochemical impedance spectroscopy (EIS) was used to measure changes in charge-transfer resistance (Rct).
- Telomerase activity was correlated with changes in Rct and Rct change rate.
Main Results:
- The BBS demonstrated a detection limit of 2.94 × 10^4 cells/mL for telomerase-positive extracts.
- Significant changes in Rct were observed upon exposure to telomerase.
- Preliminary studies indicated the potential to differentiate endometrial adenocarcinoma samples based on TA presence.
Conclusions:
- The developed BBS is a promising tool for sensitive telomerase activity detection.
- The technology shows potential for application as a portable cancer biomarker sensor.
- Further validation is needed, but the BBS shows feasibility for clinical diagnostics, particularly for endometrial cancer.
More Related Videos
14:53A Microfluidic-based Electrochemical Biochip for Label-free DNA Hybridization Analysis
Published on: September 10, 2014
13:42Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
Published on: September 19, 2017